Antonio P. M.
- Country
- Spain
- Department
- Servicio de Hemato-Oncología Pediátrica
Research Overview
- A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetate in Paediatric Subjects from Birth to <18 Years of Age, Receiving Systemic Antifungals as Prophylaxis for Invasive Fungal Infection or to Treat a Suspected or Confirmed Fungal Infection
- Phase I/II Safety of Intracerebral CART45RA‑NKG2D Cell Therapy with Autologous IL‑15‑Stimulated NK Cells in Pediatric and Young Adult Patients with High‑Grade CNS Tumors
- Phase I Evaluation of CART45RA-NKG2D and CART 19/22 T Cells in Refractory/Relapsed Acute Lymphoblastic Leukemia in Pediatric and Young Adult Cohorts
Data & Insights
Has run more than one trial at 14 of 104 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating Langerhans Cell Histiocytosis (LCH) and pediatric sarcomas, with particular emphasis on innovative therapeutic approaches for children and adolescents.
- Multi-system LCH management
- Advanced sarcoma treatment
- Pediatric cancer care protocols
Their work extends to developing targeted treatments for complex pediatric cancers requiring specialized interventions.
Cellular Immunotherapy
Focus on advanced CAR-T cell therapy and NK cell-based treatments for pediatric and adolescent patients with resistant cancers.
- NKG2D CAR cell applications
- Activated NK cell infusions
- Immunotherapy protocols
The investigator develops personalized cellular therapy approaches for treatment-resistant malignancies.
Hematologic Malignancies
Expertise in treating refractory/relapsed acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma in young patients.
- Novel leukemia treatments
- Lymphoma therapy protocols
- Antifungal management
Their research encompasses comprehensive treatment strategies for resistant blood cancers in pediatric populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.